News | October 26, 2010

Study Shows Wi-Fi Signals Affect Heart Rate


October 26, 2010 – Cordless phones, which transmit a similar pulsed signal as Wi-Fi networks at 2.4 gigahertz, have been shown to impact heart rate according to new research published in the European Journal of Oncology.

The study validates the complaints of “electrosensitivity” by increasing numbers of people across the globe, and demonstrated immediate effects on heart rate, in some cases causing it to almost double.

“What we found is what many people have said for a long time about devices that emit microwaves,” said professor Magda Havas, Ph.D., of the environmental and resources studies department at Trent University, Canada, and leader of the study. “People don’t just feel ill, their heart begins to race and this is measurable with medical heart monitoring devices.”??

The volunteers did not know when the phone was on or off and 40 percent of subjects had a moderate to severe reaction only when the phone’s base station was on and emitting microwaves. Those who responded experienced arrhythmia (irregular beats of the heart) and/or tachycardia (rapid heart rate). The symptoms were often accompanied by feelings of pain or pressure in the chest and anxiety that would appear and disappeared for no apparent reason.??

Havas’ study adds to the growing interest in the health effects of cell phones, which also transmit microwave radiation. It also raises serious concern about risks of exposing schoolchildren to Wi-Fi networks, providing a possible explanation for why some children in schools are being diagnosed with, and medicated for, heart irregularities that they believe may linked to Wi-Fi.

“While not everyone who is electrically sensitive responds in this manner, those who do will have difficulty being in environments where microwave radiation is present, which is virtually everywhere in our modern, wireless culture,” Havas said. “Cordless phones and cell phones as well as wireless computers and Wi-Fi networks generate this form of microwave radiation.”??

Additional symptoms include headaches, fatigue, difficulty concentrating, poor short-term memory, difficulty sleeping, skin problems, tinnitus, nausea and dizziness.

For more information: http://electromagnetichealth.org/wp-content/uploads/2010/10/Havas_HRV_Ramazzini1.pdf


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now